Geron (GERN) Current Leases (2019 - 2026)
Geron's (GERN) quarterly Current Leases came in at $1.0 million in Q2 2026, up 2.63% year-over-year from $987000.0 in Q2 2025, and up 0.6% quarter-over-quarter from $1.0 million in Q1 2026.
Analysis
Geron (GERN) Current Leases (2019 - 2026) Analysis & Trends
Geron has disclosed Current Leases across 8 years of filings, most recently posting $1.0 million for Q2 2026.
- In Q2 2026, Current Leases rose 2.63% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (up 2.63% YoY), while the FY2025 annual figure was $1.0 million, up 2.67% from the prior year.
- Current Leases came in at $1.0 million for Q2 2026 at Geron, up from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.0 million in Q2 2026 to a low of $786000.0 in Q2 2023.
- Average Current Leases over 5 years is $950722.2, with a median of $958000.0 recorded in 2024.
- Year-over-year, Current Leases fell 13.91% in 2023 and climbed 22.26% in 2024.
- Over 5 years, Current Leases stood at $925000.0 in 2022, then climbed by 2.59% to $949000.0 in 2023, then increased by 2.63% to $974000.0 in 2024, then grew by 2.67% to $1.0 million in 2025, then gained by 1.3% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.0 million in Q2 2026, $1.0 million in Q1 2026, and $1.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | 1.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 981,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 968,000.00 |
| Jun 30, 2024 | 961,000.00 |
| Mar 31, 2024 | 955,000.00 |
| Dec 31, 2023 | 949,000.00 |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 786,000.00 |
| Mar 31, 2023 | 931,000.00 |
| Dec 31, 2022 | 925,000.00 |
| Sep 30, 2022 | 919,000.00 |
| Jun 30, 2022 | 913,000.00 |
| Mar 31, 2022 | 907,000.00 |
| Dec 31, 2021 | 901,000.00 |
| Sep 30, 2021 | 895,000.00 |